Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NK-Cell Lymphomas”

468 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 468 results

Early research (Phase 1)Study completedNCT00470405
What this trial is testing

Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma

Who this might be right for
LymphomaSolid Tumor
Vanderbilt-Ingram Cancer Center 25
Large-scale testing (Phase 3)Study completedNCT00412360
What this trial is testing

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+2 more
Medical College of Wisconsin 224
Early research (Phase 1)UnknownNCT04887012
What this trial is testing

Clinical Study of HLA Haploidentical CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL

Who this might be right for
B-cell Non Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 25
Early research (Phase 1)WithdrawnNCT00458744
What this trial is testing

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Children's Oncology Group
Early research (Phase 1)Active Not RecruitingNCT04526834
What this trial is testing

Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaPeripheral T Cell LymphomaExtranodal NK/T-cell Lymphoma+2 more
Tessa Therapeutics 21
Early research (Phase 1)Ended earlyNCT00996359
What this trial is testing

Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Medicine and Dentistry of New Jersey 4
Testing effectiveness (Phase 2)Study completedNCT01261247
What this trial is testing

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+18 more
Mayo Clinic 41
Not applicableStudy completedNCT02764281
What this trial is testing

MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma

Who this might be right for
Extranodal NK-T-Cell Lymphoma, Nasal Type
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 53
Early research (Phase 1)Ended earlyNCT01116154
What this trial is testing

Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+28 more
City of Hope Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT02825147
What this trial is testing

Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma

Who this might be right for
Nasal Type Extranodal NK/T-Cell Lymphoma
Ruijin Hospital 40
Large-scale testing (Phase 3)UnknownNCT03623087
What this trial is testing

SIMPLE Chemotherapy for NK Lymphoma/Leukaemia

Who this might be right for
Non-Hodgkin's Lymphoma, RelapsedNon-Hodgkin T-cell LymphomaNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
The University of Hong Kong 68
Not applicableStudy completedNCT02733458
What this trial is testing

GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma

Who this might be right for
Extranodal NK-T-Cell Lymphoma, Nasal Type
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 52
Testing effectiveness (Phase 2)UnknownNCT04405375
What this trial is testing

GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Beijing Tongren Hospital 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT03728972
What this trial is testing

Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type

Who this might be right for
NK/T-Cell Lymphoma of Nasal Cavity (Diagnosis)NK/T-Cell Lymphoma of Nasopharynx (Diagnosis)
Memorial Sloan Kettering Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT03052933
What this trial is testing

Copanlisib and Gemcitabine in Relapsed/Refractory PTCL

Who this might be right for
Mature T-Cell and NK-Cell Neoplasm
Chonnam National University Hospital 28
Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Not applicableWithdrawnNCT01769911
What this trial is testing

Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell Lymphoma+42 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT01799083
What this trial is testing

Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas

Who this might be right for
Solid TumorsB Cell Lymphoma
Han weidong 100
Testing effectiveness (Phase 2)UnknownNCT05149170
What this trial is testing

Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL

Who this might be right for
Early-stageExtranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Study completedNCT00374699
What this trial is testing

Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas

Who this might be right for
Peripheral T-Cell LymphomasNon-Hodgkin Lymphoma
Samsung Medical Center 55
Load More Results